In: point of care
27 MayADEXUSDx COVID-19 Antibody Test Receives FDA Emergency Use Authorization for Point-of-Care Deployment Across U.S.
SPRINGDALE, AR, May 25, 2021 – NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19…Read More
ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has…Read More
Introducing the ADEXUSDx COVID-19 Test At NOWDiagnostics, we’re always looking for ways to respond to community needs. Our new, rapid ADEXUSDx…Read More
NOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test The ADEXUSDx® COVID-19 Test is a rapid serology test that detects total antibodies…Read More
What’s the Definition of “Point of Care Testing?” The phrase “point of care testing” is used often in healthcare, but what…Read More